Compare LSTR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTR | AMRX |
|---|---|---|
| Founded | 1988 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.8B |
| IPO Year | 1994 | 2018 |
| Metric | LSTR | AMRX |
|---|---|---|
| Price | $212.69 | $17.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $173.83 | $15.60 |
| AVG Volume (30 Days) | 404.5K | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | ★ 1.16 | 0.19 |
| Revenue | ★ $4,743,760,000.00 | N/A |
| Revenue This Year | $6.89 | $4.48 |
| Revenue Next Year | $9.05 | $7.13 |
| P/E Ratio | $182.04 | ★ $92.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $119.40 | $7.67 |
| 52 Week High | $228.46 | $18.39 |
| Indicator | LSTR | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.00 | 66.96 |
| Support Level | $202.41 | $12.46 |
| Resistance Level | $214.80 | N/A |
| Average True Range (ATR) | 5.44 | 0.58 |
| MACD | 0.14 | -0.05 |
| Stochastic Oscillator | 83.76 | 74.48 |
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.